Listen: kidney health

As global healthcare systems face increasing pressure from aging populations, rising chronic conditions, and widening health disparities, few challenges loom as large—or as quietly—as chronic kidney disease (CKD). Often called the “silent epidemic,” CKD affects over 850 million people worldwide, many of whom are unaware of their condition until it has reached an advanced stage.

Companies like Nipro are stepping up with a bold, multi-faceted approach— prioritizing early detection, raising awareness, and delivering high-quality care for patients already living with kidney failure. From diagnostics and vascular imaging to advanced dialysis ecosystems, Nipro is helping redefine what kidney care can look like—grounded in precision, accessibility, and compassion.

Looking ahead to a more connected and patient-centered future, Nipro continues to innovate in areas that directly impact kidney health—whether it’s infection prevention, digital dialysis systems, or individualizing therapies to match local infrastructure and patient needs.

Aston spoke to Annick Somers, chief marketing officer at Nipro and Serge Kemp, CEO of Nipro.